NSE · ARVEE
Arvee Laboratories (India) Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,367
of 5,072 stocks
▲ 1211W
Peak #2,367 · 27 Sep 2026
Arvee Laboratories (India) Limited is a microcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, remains firmly promoter-controlled, with promoters holding 74%, and is seeing revenue contract sharply.
Market Cap
234.94 Cr
P/E Ratio
93.10
P/B Ratio
6.95
ROE
7.48%
ROCE
7.46%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 17.23 Cr | 10.80 Cr | 9.78 Cr | 3.45 Cr |
| Net Profit | 1.69 Cr | 52.02 L | 1.83 Cr | 1.01 L |
| EPS | 1.54 | 0.47 | 1.66 | 0.01 |
| Operating Profit | 2.35 Cr | 93.55 L | 1.46 Cr | 5.41 L |
Shareholding pattern
Promoter
73.50%
Public
26.50%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 20 Sep 2024 | Other | Annual General Meeting |
| 15 Sep 2023 | Other | Annual General Meeting |
| 28 Jul 2022 | Other | Annual General Meeting |
| 16 Sep 2021 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.